About Michael Clayman
Form D filings for Adipo Therapeutics in 2024 list Michael Clayman as director.
Michael Clayman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Clayman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Clayman works with at each company, as listed on that company's latest Form D.
Adipo Therapeutics, LLC · Form D, Dec 11, 2024